Search
Krystal Biotech Inc
KRYSAdd to Watchlist
347.000USD
+1.450+0.42%
Close 09-11 16:00（ET）
10.26BMarket Cap
44.75P/E TTM
Krystal Biotech Inc (KRYS) Stock Price Target & Forecast
Analyst Rating
Based on 12 analysts giving stock ratings to Krystal Biotech Inc in the past month.
Buy
5 Strong Buy
6 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
364.303USD+4.66%
KRYS Analyst Recommendation Trends
In the current month, KRYS has received 6 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. KRYS average Analyst price target in the last month is 364.303.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
5
5
5
5
5
5
4
4
6
7
6
6
6
7
7
7
1
1
1
1
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12
13
12
12
11
12
12
12
KRYS Analyst Rating for Peer Comparison
Updated: Sep 11, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Pfizer Inc
PFE
5
6
19
1
1
32
Regeneron Pharmaceuticals Inc
REGN
6
15
11
0
0
32
Merck & Co Inc
MRK
8
14
10
0
0
32
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, KRYS EPS is projected to reach 1.844 in FY2026Q3, following reported EPS of 1.855 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
1.41
1.42
1.66
1.84
2.16
Actual
1.77
1.91
1.85
--
--
Surprise
+25.41%
+34.47%
+12.03%
--
--
FAQs
What is Krystal Biotech Inc's expected revenue for the next quarter?
Krystal Biotech Inc's expected revenue is 130.14M.
What is Krystal Biotech Inc's price target?
Analysts forecast that Krystal Biotech Inc's price target is USD 364.30, with the highest forecast at USD 474.00 and the lowest forecast at USD 215.00.
How have Krystal Biotech IncKRYS's recent earnings per share performed?
The market expectation was USD 1.85, while Krystal Biotech IncKRYS's earnings per share (EPS) for the previous quarter was USD 1.91. EPS for the next quarter is expected at USD 1.84.
What is the analyst rating for Krystal Biotech Inc?
Based on the ratings of Krystal Biotech Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.